Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
AA
|
Timothy Patrick Flynn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,933 Added 5.14% |
$34,991
$11.93 p/Share
|
Oct 05
2020 |
AA
|
Steven W Williams |
BUY
Grant, award, or other acquisition
|
Direct | 2,514 Added 4.63% |
$29,992
$11.93 p/Share
|
Oct 05
2020 |
AOS
|
Wallace E Goodwin
SVP; President, Lochinvar, LLC |
SELL
Open market or private sale
|
Direct | 4,800 Reduced 22.97% |
$264,000
$55.0 p/Share
|
Oct 05
2020 |
AOS
|
Wallace E Goodwin
SVP; President, Lochinvar, LLC |
BUY
Exercise of conversion of derivative security
|
Direct | 4,800 Added 18.68% |
$55,152
$11.49 p/Share
|
Oct 05
2020 |
BSY
|
Brian F. Hughes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,136 Added 5.48% |
$24,992
$22.0 p/Share
|
Oct 05
2020 |
XYL
|
David Flinton
Senior Vice President |
SELL
Open market or private sale
|
Direct | 33,386 Reduced 59.18% |
$2,872,865
$86.05 p/Share
|
Oct 05
2020 |
XYL
|
David Flinton
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 30,657 Added 44.98% |
$1,244,368
$40.59 p/Share
|
Oct 05
2020 |
LEN
|
David M Collins
VP & Controller |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 29.94% |
$1,700,000
$85.0 p/Share
|
Oct 05
2020 |
HRL
|
Swen Neufeldt
GROUP VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 5,271 Reduced 22.99% |
$259,860
$49.3 p/Share
|
Oct 05
2020 |
HRL
|
Swen Neufeldt
GROUP VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 30.37% |
$154,900
$15.49 p/Share
|
Oct 05
2020 |
RSMDF
|
David Pendarvis
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 5,919 Reduced 4.17% |
$1,006,644
$170.07 p/Share
|
Oct 05
2020 |
RSMDF
|
David Pendarvis
Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,919 Added 4.0% |
$341,881
$57.76 p/Share
|
Oct 05
2020 |
REGN
|
Joseph L Goldstein
Director |
SELL
Open market or private sale
|
Direct | 9,212 Reduced 62.01% |
$5,527,200
$600.0 p/Share
|
Oct 05
2020 |
REGN
|
Joseph L Goldstein
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 9,212 Added 38.28% |
$4,790,332
$520.01 p/Share
|
Oct 05
2020 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.52% |
$891
$1.32 p/Share
|
Oct 05
2020 |
TDOC
|
Adam C Vandervoort
CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct | 2,610 Reduced 92.88% |
$580,621
$222.46 p/Share
|
Oct 05
2020 |
TDOC
|
Adam C Vandervoort
CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct | 2,610 Added 48.15% |
$79,396
$30.42 p/Share
|
Oct 05
2020 |
GROW
|
Lisa Callicotte
CFO |
BUY
Other acquisition or disposition
|
Direct | 800 Added 3.87% |
$2,000
$2.5 p/Share
|
Oct 05
2020 |
GROW
|
Thomas F Lydon Jr
Director |
BUY
Other acquisition or disposition
|
Direct | 800 Added 4.37% |
$2,000
$2.5 p/Share
|
Oct 05
2020 |
GROW
|
Jerold H Rubinstein
Director |
BUY
Other acquisition or disposition
|
Direct | 800 Added 22.22% |
$2,000
$2.5 p/Share
|
Oct 05
2020 |
GROW
|
Roy D Terracina
Director |
BUY
Other acquisition or disposition
|
Direct | 800 Added 1.24% |
$2,000
$2.5 p/Share
|
Oct 05
2020 |
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 14 Added 0.01% |
$6,372
$455.11 p/Share
|
Oct 05
2020 |
TRC
|
Daniel R Tisch
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,204 Added 2.04% |
$17,037
$14.15 p/Share
|
Oct 05
2020 |
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 296 Added 1.71% |
$4,961
$16.76 p/Share
|
Oct 05
2020 |
CZNC
|
Timothy E Schoener |
BUY
Open market or private purchase
|
Direct | 296 Added 13.02% |
$4,961
$16.76 p/Share
|
Oct 05
2020 |
CZNC
|
Bobbi J Kilmer |
BUY
Open market or private purchase
|
Direct | 371 Added 5.75% |
$6,218
$16.76 p/Share
|
Oct 05
2020 |
CZNC
|
Robert G Loughery |
BUY
Open market or private purchase
|
Direct | 296 Added 17.2% |
$4,961
$16.76 p/Share
|
Oct 05
2020 |
MRK
|
Robert M Davis
Chairman, CEO & President |
SELL
Open market or private sale
|
Direct | 251,273 Reduced 59.5% |
$20,360,651
$81.03 p/Share
|
Oct 05
2020 |
MRK
|
Robert M Davis
Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct | 251,273 Added 37.3% |
-
|
Oct 05
2020 |
ACN
|
Richard P Clark
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 95 Added 0.9% |
$21,232
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
James O Etheredge
Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.76% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.53% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct | 59 Added 0.03% |
$13,186
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.59% |
$24,360
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 1.3% |
$31,289
$223.49 p/Share
|
Oct 05
2020 |
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 90 Added 0.38% |
$20,114
$223.49 p/Share
|
Oct 05
2020 |
CFB
|
David L. O'Toole
CHIEF INVESTMENT OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.09% |
$9,500
$9.5 p/Share
|
Oct 05
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,058,100
$70.54 p/Share
|
Oct 05
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$235,200
$15.68 p/Share
|
Oct 05
2020 |
CUE
|
Anish Suri
PRESIDENT AND CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,800 Reduced 14.43% |
$159,740
$16.3 p/Share
|
Oct 05
2020 |
HGBL
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 27,708 Added 0.63% |
$51,537
$1.86 p/Share
|
Oct 05
2020 |
HGBL
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 27,708 Added 0.63% |
$51,537
$1.86 p/Share
|
Oct 05
2020 |
JSD
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,701 Added 0.14% |
$21,211
$12.47 p/Share
|
Oct 05
2020 |
JRO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 128,002 Added 2.77% |
$1,063,697
$8.31 p/Share
|
Oct 05
2020 |
TIPT
|
Michael Gene Barnes
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 2,852 Added 0.03% |
$14,203
$4.98 p/Share
|
Oct 05
2020 |
LQDT
|
William P Angrick Iii
Chairman of the Board and CEO |
BUY
Open market or private purchase
|
Indirect | 49,194 Added 0.9% |
$389,125
$7.91 p/Share
|
Oct 05
2020 |
CSTL
|
David S Kabakoff
Director |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 2.48% |
$1,302,250
$52.09 p/Share
|
Oct 05
2020 |
IESC
|
Jeffrey L Et Al Gendell
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 380 Added 0.0% |
-
|
Oct 05
2020 |
GBX
|
Mark J Rittenbaum
EVP, Chief Comm & Leasing Off |
SELL
Open market or private sale
|
Direct | 4,067 Reduced 6.58% |
$132,055
$32.47 p/Share
|
Oct 05
2020 |
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 987 Reduced 0.9% |
$22,178
$22.47 p/Share
|
Oct 05
2020 |